The State-by-State
Rules List

Alabama strictly limits hemp products to low-dose edibles via ABC-licensed retailers, calculating compliance using a total THC standard. All smokable hemp, THCA flower, and synthesized cannabinoids are strictly prohibited and actively prosecuted.

Alaska routes all intoxicating hemp products exclusively into its licensed adult-use cannabis system. Selling Delta-8 or THCA outside of an AMCO-licensed dispensary is prosecuted identically to illicit marijuana distribution.

Under a binding 2024 Attorney General opinion (I24-005), all hemp-synthesized intoxicants are classified as Schedule I controlled substances unless sold in a licensed dispensary. General retail sales are completely criminalized.

Arkansas enforces a total ban on all intoxicating hemp derivatives, classifying them as Schedule VI controlled substances. Act 629 (2023) is fully enforceable following the lifting of a federal injunction in June 2025.

California has passed AB 8, banning all inhalable hemp products and synthetic cannabinoids from general retail. Phase 1 takes effect Jan 1, 2026, routing all intoxicating hemp through licensed cannabis dispensaries only.

Colorado permits only low-dose, high-CBD hemp products in general retail, enforcing a strict 1.25mg THC cap and a 15:1 CBD-to-THC ratio. Higher potency products and all chemically converted cannabinoids are banned from standard retail.

Connecticut utilizes a tiered dosage system, capping general retail hemp edibles at 0.5mg per container. Any product exceeding 5mg is classified as "high-THC" and restricted entirely to licensed cannabis dispensaries.

Delaware classifies Delta-8 and other THC isomers as Schedule I controlled substances, strictly prohibiting their sale. THCA flower is universally banned, and the state maintains a separate, highly regulated adult-use cannabis program.

Florida currently operates a broadly legal hemp market for adults 21+, despite heavy regulatory scrutiny on packaging and labeling. A comprehensive ban on Delta-8 and THCA (SB 1698) was vetoed by Governor DeSantis in mid-2024.

Hawaii prohibits the sale of intoxicating hemp-derived cannabinoids, including Delta-8 and THCA. Edibles and inhalables are severely restricted outside of the highly constrained medical cannabis framework.

Idaho maintains the strictest hemp laws in the United States, mandating that all hemp products contain 0.0% detectable THC. All THC isomers, THCA, and standard Delta-9 products are outright felonies.

While currently treated as an extension of the adult-use framework, SB 3222 (2026) officially reclassifies all intoxicating hemp exceeding 0.4mg per container to dispensary-only status, aligning with the impending federal deadline.

Indiana strictly prohibits all smokable hemp products, rendering THCA flower completely illegal. However, hemp-derived edibles and Delta-8 currently exist in a contested legal gray area permitted in standard retail.

Iowa bans all inhalable hemp products and explicitly classifies Delta-8 and other synthetic isomers as controlled substances. Consumable edibles are severely capped at 4mg per serving and 10mg per container.

Kansas utilizes a total-THC interpretation that effectively bans all smokable THCA flower and vapes. A binding 2021 Attorney General opinion declared Delta-8 THC unlawful, though low-dose edibles operate in a murky gray area.

Kentucky heavily regulates the market through a state hemp program. Raw smokable flower is restricted, and intoxicating hemp beverages are capped at 5mg and routed primarily through liquor distribution channels as of 2026.

Louisiana strictly bans smokable hemp and THCA flower. The state imposes a strict regulatory framework on edibles, capping them at 5mg of THC per serving, while inhalable Delta-8 products are heavily restricted.

Maine follows the baseline federal 0.3% standard with minimal interference. There are no state-mandated milligram caps for hemp edibles, though strict 21+ age verification and packaging rules apply.

Maryland categorizes any product exceeding 0.5mg of THC per serving as intoxicating cannabis, legally barring Delta-8, THCA, and synthetics from general retail and forcing them into licensed dispensaries.

Massachusetts aggressively restricts intoxicating hemp products to the licensed cannabis channel. State regulations passed in 2026 bar hemp edibles from open retail and limit THC beverages to 5mg via licensed liquor/cannabis avenues.

Michigan mandates that only state-licensed cannabis companies may manufacture, distribute, or sell Delta-8 and other intoxicating hemp cannabinoids. Unregulated general retail is strictly prohibited.

Minnesota pioneered a unique low-dose framework, capping all hemp-derived edibles and beverages at 5mg per serving and 50mg per package. All THCA flower and inhalable synthetics are explicitly banned from retail.

Mississippi maintains a highly restrictive enforcement environment. An Attorney General opinion (2025-00219) effectively criminalized recreational THCA and Delta-8 products outside of narrow medical parameters.

While previously operating as an open market, Missouri enacted HB 2641/SB 904, establishing a comprehensive dispensary-only ban for intoxicating hemp products that takes full effect on November 12, 2026.

Montana enforces a "detectable THC" retail ban, essentially pushing all products with more than 0.5mg of THC into the licensed adult-use cannabis dispensary system. General retail of Delta-8 and THCA is strictly prohibited.

Nebraska is de jure open under the Hemp Farming Act, but operates under fragile conditions. A state ban bill stalled, but aggressive Attorney General and Gubernatorial pressure has led to localized enforcement and raids.

Nevada officially classifies Delta-8 and other synthetic THC isomers as Schedule I controlled substances if sold outside the licensed cannabis channel. General retail is entirely barred from selling intoxicating hemp.

New Hampshire operates in a contested legal gray area. Synthetic cannabinoids like Delta-8 are highly restricted, and THCA flower faces stringent local enforcement despite lack of a sweeping statutory ban.

New Jersey implemented severe restrictions effective January 1, 2025, banning all floral and smokable hemp at general retail. Consumables are strictly capped at 5mg per serving and require ATC permits.

New Mexico permits THCA but heavily restricts chemically synthesized isomers. Delta-8, Delta-10, and HHC face rigorous state oversight and are increasingly pushed toward the state's licensed cannabis infrastructure.

The New York Cannabis Control Board (CCB) has aggressively banned Delta-8, THCA, and other intoxicating hemp derivatives from unlicensed retail, classifying them as illicit marijuana products to protect the dispensary market.

North Carolina is currently one of the few states operating an open, broadly legal market for Delta-8, THCA, and other hemp derivatives. Mail delivery is permitted, though the upcoming federal changes will upend local commerce.

North Dakota strictly utilizes a total-THC standard and actively restricts the sale of synthetic isomers. The state classifies chemically modified cannabinoids as controlled substances, effectively banning Delta-8 and THCA.

Oregon explicitly bans artificially derived cannabinoids including Delta-8, Delta-10, and HHC. THCA is heavily restricted and permitted exclusively through OLCC-licensed adult-use dispensaries.

Pennsylvania restricts Delta-8 and synthetic isomers but currently permits THCA flower. However, SB 49 (introduced March 2026) proposes aligning the state with a strict total-THC standard, severely threatening the THCA market.

Rhode Island outright bans THCA flower and synthetic cannabinoids. The state Cannabis Control Commission is also actively moving to halt the sale of THC-infused beverages at locations holding liquor licenses.

South Carolina is de jure open for hemp products, but operates under immense threat from hostile enforcement. The State Law Enforcement Division (SLED) and Attorney General routinely prosecute Delta-8 and THCA possession.

South Dakota strictly bans all synthetic and intoxicating hemp derivatives. HB 1125 (2024) made it entirely illegal to sell Delta-8, Delta-9, THCA, and HHC outside of highly restricted channels, leading to active seizures.

Tennessee passed HB 1376 (2025), which phases out earlier THCA protections. Effective July 1, 2026, THCA flower is entirely banned, and compliant edibles are hard-capped at 15mg and restricted to licensed 21+ retail.

Texas is highly hostile. DSHS reinstated Schedule I status for Delta-8, Delta-10, and THCP, enforceable since July 31, 2026. A separate rule adopting a total-THC standard re-banned smokable THCA flower on June 5, 2026.

Utah passed HB 54 in 2025, completely banning all synthetic and chemically converted cannabinoids. Registered hemp products are strictly capped at 5mg and restricted to permit-gated retail spaces.

Vermont strictly confines Delta-8, THCA, and all artificially derived cannabinoids to its regulated adult-use cannabis dispensaries. Selling intoxicating hemp in general retail is explicitly prohibited by state statute.

Virginia utilizes a strict total-THC calculation and enforces severe potency limits that effectively ban Delta-8, THCA, and HHC from standard retail, treating them as unapproved synthetic intoxicants.

Washington State prohibits the chemical synthesis of cannabinoids, barring Delta-8, HHC, and THC-O. High-THCA flower and all hemp intoxicants are entirely restricted to licensed LCB dispensaries.

West Virginia passed SB 546 in 2023, classifying Delta-8 and Delta-10 as Schedule I controlled substances. Hemp-derived Delta-9 edibles are permitted, but THCA flower operates under highly questionable legality.

Wyoming explicitly bans Delta-8, THCA, and synthetic isomers. Crucially, the state criminalizes the receipt of direct-to-consumer shipments, transferring severe legal risk directly onto the consumer.